Review
doi: 10.1007/978-1-4613-1713-5_7.
Interferon therapy for lymphoproliferative disorders
- PMID: 2484433
- DOI: 10.1007/978-1-4613-1713-5_7
Item in Clipboard
Review
Interferon therapy for lymphoproliferative disorders
Cancer Treat Res.
1988.
No abstract available
Similar articles
-
Biological molecules in the treatment of hematological disorders.Sangre (Barc). 1989 Feb;34(1):53-8. Sangre (Barc). 1989. PMID: 2469130 Review. No abstract available.
-
Recombinant alpha-interferons, thyroid irradiation and thyroid disease.Acta Haematol. 1991;85(3):160-3. doi: 10.1159/000204881. Acta Haematol. 1991. PMID: 1904180
-
Biotherapy of chronic myelogenous leukemia with interferon.Semin Oncol. 1988 Oct;15(5 Suppl 5):14-20. Semin Oncol. 1988. PMID: 2461592 Review. No abstract available.
-
[Interferon and chronic myeloid leukemia].Sangre (Barc). 1990 Jun;35(3):213-7. Sangre (Barc). 1990. PMID: 2204124 Review. Spanish. No abstract available.
-
A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.Adv Exp Med Biol. 1991;309A:69-73. doi: 10.1007/978-1-4899-2638-8_15. Adv Exp Med Biol. 1991. PMID: 1686352 No abstract available.
Cited by
-
Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2.Cancer Immunol Immunother. 1992;35(6):401-11. doi: 10.1007/BF01789019. Cancer Immunol Immunother. 1992. PMID: 1394343 Free PMC article. Clinical Trial.